Lilia Pineda

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

Sandra Navarra, Renato Guzmán, A Gallacher et al. · The Lancet · 2011 · 2K citations

Rheumatology, Autoimmune Disease, Lupus +6

Trial of Anifrolumab in Active Systemic Lupus Erythematosus

Eric F. Morand, Richard Furie, Yoshiya Tanaka et al. · New England Journal of Medicine · 2019 · 1.2K citations · Full text

Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus

William Stohl, Falk Hiepe, Kevin Latinis et al. · Arthritis & Rheumatism · 2012 · 408 citations · Full text

Apremilast for Behçet’s Syndrome — A Phase 2, Placebo-Controlled Study

Gülen Hatemi, Melike Melikoğlu, Recep Tunç et al. · New England Journal of Medicine · 2015 · 229 citations · Full text

Long‐term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus

Joan T. Merrill, Ellen M. Ginzler, Daniel J. Wallace et al. · Arthritis & Rheumatism · 2012 · 117 citations